These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37555348)

  • 1. Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
    Pascual-Antón L; Sandoval P; González-Mateo GT; Kopytina V; Tomero-Sanz H; Arriero-País EM; Jiménez-Heffernan JA; Fabre M; Egaña I; Ferrer C; Simón L; González-Cortijo L; Sainz de la Cuesta R; López-Cabrera M
    J Pathol; 2023 Oct; 261(2):238-251. PubMed ID: 37555348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
    Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
    J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
    Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
    J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
    Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
    J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ΔNp73 and its effector targets promote colorectal peritoneal carcinosis and predict survival.
    Pastor-Morate D; Amigo-Morán L; Garranzo-Asensio M; Rejas-González R; Carnicero P; Rodríguez N; Pérez-Robledo JP; Barderas R; Prieto-Nieto I; Domínguez G
    J Pathol; 2024 Jul; 263(3):328-337. PubMed ID: 38629257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis.
    Demuytere J; Ceelen W; Van Dorpe J; Hoorens A
    Exp Mol Pathol; 2020 Aug; 115():104442. PubMed ID: 32305340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
    Pascual-Antón L; Cardeñes B; Sainz de la Cuesta R; González-Cortijo L; López-Cabrera M; Cabañas C; Sandoval P
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
    Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
    Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.
    Peng Y; Kajiyama H; Yuan H; Nakamura K; Yoshihara M; Yokoi A; Fujikake K; Yasui H; Yoshikawa N; Suzuki S; Senga T; Shibata K; Kikkawa F
    Cancer Lett; 2019 Feb; 442():181-192. PubMed ID: 30429105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
    Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
    J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.
    Wang C; Wang J; Shen X; Li M; Yue Y; Cheng X; Lu W; Wang X; Xie X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):101. PubMed ID: 33726799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
    Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
    Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells.
    Wei M; Yang T; Chen X; Wu Y; Deng X; He W; Yang J; Wang Z
    Oncotarget; 2017 Jun; 8(26):42262-42271. PubMed ID: 28178689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin Deposit on the Peritoneal Surface Serves as a Niche for Cancer Expansion in Carcinomatosis Patients.
    Shahid S; Iman A; Matti U; Rachid K; Assaf A; Eveno C; Marc P; Massoud M
    Neoplasia; 2019 Nov; 21(11):1091-1101. PubMed ID: 31734630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas.
    Tomero-Sanz H; Jiménez-Heffernan JA; Fernández-Chacón MC; Cristóbal-García I; Sainz de la Cuesta R; González-Cortijo L; López-Cabrera M; Sandoval P
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.
    Lv ZD; Wang HB; Dong Q; Kong B; Li JG; Yang ZC; Qu HL; Cao WH; Xu HM
    Mol Cell Biochem; 2013 May; 377(1-2):177-85. PubMed ID: 23392771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
    Wilson RB; Archid R; Reymond MA
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis.
    Kitami K; Yoshihara M; Tamauchi S; Sugiyama M; Koya Y; Yamakita Y; Fujimoto H; Iyoshi S; Uno K; Mogi K; Ikeda Y; Yokoi A; Yoshikawa N; Nishino K; Niimi K; Nawa A; Enomoto A; Kajiyama H
    Matrix Biol; 2022 May; 109():70-90. PubMed ID: 35339636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis.
    Rynne-Vidal A; Jiménez-Heffernan JA; Fernández-Chacón C; López-Cabrera M; Sandoval P
    Cancers (Basel); 2015 Sep; 7(4):1994-2011. PubMed ID: 26426054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
    Colombo PE; Boustta M; Poujol S; Jarlier M; Bressolle F; Teulon I; Ladjemi MZ; Pinguet F; Rouanet P; Vert M
    Gynecol Oncol; 2011 Sep; 122(3):632-40. PubMed ID: 21665252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.